These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26271128)

  • 1. Anemia and Outcome in Outpatients With Peripheral Artery Disease.
    Perez P; Esteban C; Caballero PE; Muñoz-Torrero JF; Soria MT; Aguilar E; Rodríguez LR; Sahuquillo JC; Díaz AM; Monreal M;
    Angiology; 2016 May; 67(5):484-9. PubMed ID: 26271128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
    Altes P; Perez P; Esteban C; Sánchez Muñoz-Torrero JF; Aguilar E; García-Díaz AM; Álvarez LR; Jiménez PE; Sahuquillo JC; Monreal M;
    Angiology; 2018 Jul; 69(6):507-512. PubMed ID: 29113452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
    Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
    Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption and outcome in stable outpatients with peripheral artery disease.
    Garcia-Diaz AM; Marchena PJ; Toril J; Arnedo G; Muñoz-Torrero JF; Yeste M; Aguilar E; Monreal M;
    J Vasc Surg; 2011 Oct; 54(4):1081-7. PubMed ID: 21684714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcome in stable outpatients with peripheral artery disease.
    Sanclemente C; Yeste M; Suarez C; Coll R; Aguilar E; Sahuquillo JC; Lerma R; Monreal M;
    Intern Emerg Med; 2014 Feb; 9(1):69-77. PubMed ID: 23054402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease.
    Bernaudo D; Coll R; Sánchez Muñoz-Torrero JF; Pascual MT; García-Díaz AM; Alvarez LR; Monreal M;
    Atherosclerosis; 2013 Jul; 229(1):258-62. PubMed ID: 23714334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol and outcome in outpatients with peripheral artery disease.
    Perez P; Esteban C; Sauquillo JC; Yeste M; Manzano L; Mujal A; Jiménez Caballero PE; Aguilar E; Sánchez Muñoz-Torrero JF; Monreal M;
    Thromb Res; 2014 Aug; 134(2):331-5. PubMed ID: 24951338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease.
    Desormais I; Aboyans V; Bura A; Constans J; Cambou JP; Messas E; Labrunie A; Lacroix P
    Eur J Vasc Endovasc Surg; 2014 Aug; 48(2):202-7. PubMed ID: 24935912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
    Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
    Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease.
    Alvarez LR; Balibrea JM; Suriñach JM; Coll R; Pascual MT; Toril J; López-Jiménez L; Monreal M;
    Eur J Prev Cardiol; 2013 Jun; 20(3):486-95. PubMed ID: 21968571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.
    Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M;
    Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic Blood Pressure and Outcomes in Stable Outpatients with Recent Symptomatic Artery Disease: A Population-Based Longitudinal Study.
    Sánchez Muñoz-Torrero JF; Escudero-Sánchez G; Calderón-García JF; Rico-Martín S; Robles NR; Bacaicoa MA; Alcalá-Pedrajas JN; Gil-Fernández G; Monreal M; On Behalf Of The Frena Investigators
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease.
    Mehta H; Chan WC; Aday AW; Jones WS; Parmar GM; Hance K; Thors A; Alli A; Wiley M; Tadros P; Gupta K
    J Vasc Surg; 2024 May; 79(5):1170-1178.e10. PubMed ID: 38244643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Muñoz-Torrero JFS; Zamorano J; Rico-Martín S; Rivas MD; Bacaicoa MA; Robles R; Sanchez-Bacaicoa C; Monreal M;
    Atherosclerosis; 2020 Jan; 292():84-89. PubMed ID: 31785493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
    Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
    Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac rehabilitation and outcome in stable outpatients with recent myocardial infarction.
    Coll-Fernández R; Coll R; Pascual T; Sánchez Muñoz-Torrero JF; Sahuquillo JC; Manzano L; Aguilar E; Alcala-Pedrajas JN; Alvarez LR; García-Díaz AM; Mujal A; Yeste M; Monreal M
    Arch Phys Med Rehabil; 2014 Feb; 95(2):322-9. PubMed ID: 24121084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.